THERAPEUTIC TREATMENT AGAINST GLIOBLASTOMA CANCER

Patent number:

EP21383180.3

Región de Murcia.svg
No items found.

The perivascular cells that surround the small blood vessels of vascularized tissues, known as "pericytes", are useful for developing a cell therapy against glioblastoma cancer, if the activity related to a protein degradation mechanism by which glioblastoma is previously eliminated. parasitizes the pericyte, and is known as “chaperone-mediated autophagy”. The purpose of this patent is to protect the method of isolation and in vitro production of these cells, as well as their use as a pharmaceutical composition.

Countries:
Spain
Regions:
Region of Murcia
Centers:
UNIVERSIDAD DE MURCIA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

- Modified pericytes can act as a "drug cell" against brain tumors. - The modified pericytes are capable of promoting the activation of the endogenous pericytes of the host itself and of other cells of the immune system that allow the elimination of the tumor. - The proposed strategy could be applied to the treatment of other types of tumors. - Modified pericytes may act as secreting cells for potential glioblastoma prognostic markers.

Comments

Other related patents

Food & Agro
Health

Aldoximes as NO donors, and their uses as plant architecture modifiers and in therapy

Countries
Spain
Know more
Health

IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF BREAST CANCER

Countries
Spain
Know more
Health

COMPOSITIONS FOR TREATING DISEASES RELATED TO L YSOME DISORDERS

Countries
Spain
Know more
Get back to patents directory